Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hurle

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Virulence|October 24, 2023
Microbiome diversity is a modifiable virulence factor for cryptosporidiosisGeorgina R Hurle, Julii Brainard, Kevin M Tyler
BMJ (Clinical Research Ed.)|June 20, 1998
Pay rates for junior doctors' additional hours need to be adjustedT Pickersgill, H G Kynaston, R Hurle, et al.
Nature|January 22, 1971
Shock-tube study of the nucleation of lead vapourJ B Homer, I R Hurle, P J Swain
Biochemistry|October 21, 1986
Synergism in folding of a double mutant of the alpha subunit of tryptophan synthaseM R Hurle, N B Tweedy, C R Matthews
The Journal of Urology|November 1, 1996
Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapyR Hurle, A Losa, A Ranieri, et al.
BMC Bioinformatics|February 10, 2019
Predicting clinically promising therapeutic hypotheses using tensor factorizationJin Yao, Mark R Hurle, Matthew R Nelson, et al.
Drug Discovery Today|April 3, 2019
Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunitiesDeepali Jhamb, Michal Magid-Slav, Mark R Hurle, et al.
Nature Reviews. Drug Discovery|February 11, 2017
Impact of genetically supported target selection on R&D productivityMark R Hurle, Matthew R Nelson, Pankaj Agarwal, et al.
Nature Reviews. Drug Discovery|August 31, 2016
Trial watch: Impact of genetically supported target selection on R&D productivityMark R Hurle, Matthew R Nelson, Pankaj Agarwal, et al.
Biochemistry|January 24, 1995
Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4S J Wood, R Wetzel, J D Martin, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Virulence|October 24, 2023
Microbiome diversity is a modifiable virulence factor for cryptosporidiosisGeorgina R Hurle, Julii Brainard, Kevin M Tyler
BMJ (Clinical Research Ed.)|June 20, 1998
Pay rates for junior doctors' additional hours need to be adjustedT Pickersgill, H G Kynaston, R Hurle, et al.
Nature|January 22, 1971
Shock-tube study of the nucleation of lead vapourJ B Homer, I R Hurle, P J Swain
Biochemistry|October 21, 1986
Synergism in folding of a double mutant of the alpha subunit of tryptophan synthaseM R Hurle, N B Tweedy, C R Matthews
The Journal of Urology|November 1, 1996
Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapyR Hurle, A Losa, A Ranieri, et al.
BMC Bioinformatics|February 10, 2019
Predicting clinically promising therapeutic hypotheses using tensor factorizationJin Yao, Mark R Hurle, Matthew R Nelson, et al.
Drug Discovery Today|April 3, 2019
Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunitiesDeepali Jhamb, Michal Magid-Slav, Mark R Hurle, et al.
Nature Reviews. Drug Discovery|February 11, 2017
Impact of genetically supported target selection on R&D productivityMark R Hurle, Matthew R Nelson, Pankaj Agarwal, et al.
Nature Reviews. Drug Discovery|August 31, 2016
Trial watch: Impact of genetically supported target selection on R&D productivityMark R Hurle, Matthew R Nelson, Pankaj Agarwal, et al.
Biochemistry|January 24, 1995
Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4S J Wood, R Wetzel, J D Martin, et al.
Pageof 6